Does ETONOGESTREL Cause Excessive granulation tissue? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Excessive granulation tissue have been filed in association with ETONOGESTREL (Nexplanon). This represents 0.0% of all adverse event reports for ETONOGESTREL.
8
Reports of Excessive granulation tissue with ETONOGESTREL
0.0%
of all ETONOGESTREL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Excessive granulation tissue From ETONOGESTREL?
Of the 8 reports.
Is Excessive granulation tissue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETONOGESTREL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ETONOGESTREL Cause?
No adverse event (8,827)
Complication associated with device (6,047)
Product quality issue (4,651)
Device breakage (4,140)
Incorrect product administration duration (3,974)
Device difficult to use (3,799)
Unintended pregnancy (3,707)
Device deployment issue (3,621)
Pregnancy with implant contraceptive (3,587)
Complication of device removal (3,578)
What Other Drugs Cause Excessive granulation tissue?
CARBIDOPA\LEVODOPA (117)
ADALIMUMAB (38)
BACLOFEN (31)
ZOLEDRONIC ACID (29)
ZOMETA (27)
AREDIA (21)
METHOTREXATE (19)
RITUXIMAB (13)
BECAPLERMIN (11)
PAMIDRONATE (11)
Which ETONOGESTREL Alternatives Have Lower Excessive granulation tissue Risk?
ETONOGESTREL vs ETOPOSIDE
ETONOGESTREL vs ETORICOXIB
ETONOGESTREL vs ETRASIMOD ARGININE
ETONOGESTREL vs ETRAVIRINE
ETONOGESTREL vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL